EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 159 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $225,000 | -18.5% | 7,899 | -5.7% | 0.02% | -6.2% |
| Q2 2015 | $276,000 | +15.5% | 8,379 | +0.9% | 0.02% | +14.3% |
| Q1 2015 | $239,000 | +17.7% | 8,307 | +11.5% | 0.01% | +7.7% |
| Q4 2014 | $203,000 | +31.0% | 7,452 | +2.4% | 0.01% | +18.2% |
| Q3 2014 | $155,000 | +4.7% | 7,280 | +10.5% | 0.01% | 0.0% |
| Q2 2014 | $148,000 | +17.5% | 6,588 | +31.9% | 0.01% | +10.0% |
| Q1 2014 | $126,000 | 0.0% | 4,993 | -9.2% | 0.01% | 0.0% |
| Q4 2013 | $126,000 | +32.6% | 5,497 | +10.4% | 0.01% | +11.1% |
| Q3 2013 | $95,000 | +30.1% | 4,980 | -1.2% | 0.01% | +12.5% |
| Q2 2013 | $73,000 | +9.0% | 5,040 | +5.1% | 0.01% | +14.3% |
| Q1 2013 | $67,000 | +26.4% | 4,797 | +32.0% | 0.01% | 0.0% |
| Q2 2012 | $53,000 | -23.2% | 3,634 | -15.9% | 0.01% | -12.5% |
| Q1 2012 | $69,000 | +35.3% | 4,319 | +47.0% | 0.01% | +14.3% |
| Q4 2011 | $51,000 | +24.4% | 2,939 | +10.0% | 0.01% | +16.7% |
| Q3 2011 | $41,000 | – | 2,672 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |